Metabolomic profiles of metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trials.

Federica BellerbaAnastasia Chrysovalantou ChatziioannouPaniz JasbiNivonirina RobinotPekka Keski-RahkonenAmarine TrolatBéatrice VozarSheri J HartmanAugustin ScalbertBernardo BonanniHarriet JohanssonDorothy D SearsSara Gandini

Published in: Journal of translational medicine (2022)

ClinicalTrials.gov identifier: NCT01302379 and EudraCT Protocol #: 2015-001001-14.

Keyphrases

placebo controlled
double blind
phase iii
phase ii
randomized controlled trial
study protocol
clinical trial
phase ii study
open label
squamous cell carcinoma